Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells

RM Touyz, EL Schiffrin - Pharmacological reviews, 2000 - Elsevier
Until recently, the signaling events elicited in vascular smooth muscle cells by angiotensin II
(Ang II) were considered to be rapid, short-lived, and divided into separate linear pathways …

L-NAME in the cardiovascular system—nitric oxide synthase activator?

J Kopincová, A Púzserová, I Bernátová - Pharmacological Reports, 2012 - Springer
L-arginine analogues are widely used inhibitors of nitric oxide synthase (NOS) activity both
in vitro and in vivo, with N ω-nitro-L-arginine methyl ester (L-NAME) being at the head. On …

Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease

J Blacher, K Demuth, AP Guerin, ME Safar… - … , and vascular biology, 1998 - ahajournals.org
The incremental elastic modulus of the common carotid and radial arteries is increased in
patients with end-stage renal disease (ESRD), independently of blood pressure, wall stress …

Highlights on endothelins: a review

ANAO MATEO, AA DE ARTIÑANO - Pharmacological Research, 1997 - Elsevier
The endothelins (ET) are a family of contractile peptides made up of 21 amino acids. They
are synthesised from larger precursors and they are expressed in different tissues. ET-1 is …

ETA Receptor Blockade Prevents Increased Tissue Endothelin-1, Vascular Hypertrophy, and Endothelial Dysfunction in Salt-Sensitive Hypertension

M Barton, LV d'Uscio, S Shaw, P Meyer, P Moreau… - …, 1998 - ahajournals.org
Sodium plays an important role in the pathogenesis and therapy of hypertension, a major
risk factor for cardiovascular disease. This study investigated the involvement of endothelin …

[HTML][HTML] Resveratrol protects cardiac tissue in experimental malignant hypertension due to antioxidant, anti-inflammatory, and anti-apoptotic properties

J Grujić-Milanović, V Jaćević, Z Miloradović… - International Journal of …, 2021 - mdpi.com
Hypertension is one of the most prevalent and powerful contributors of cardiovascular
diseases. Malignant hypertension is a relatively rare but extremely severe form of …

The link among nitric oxide synthase activity, endothelial function, and aortic and ventricular hypertrophy in hypertension

H Hayakawa, L Raij - Hypertension, 1997 - ahajournals.org
The adaptive changes that occur in the left ventricle (LV) and vessels in response to
hypertension, namely, muscle hypertrophy/hyperplasia, endothelial dysfunction, and …

Role of nitric oxide in the control of renin secretion

A Kurtz, C Wagner - American Journal of Physiology-Renal …, 1998 - journals.physiology.org
Because of the significant constitutive expression of NO synthases in the juxtaglomerular
apparatus, nitric oxide (NO) is considered as a likely modulator of renin secretion. In most …

[PDF][PDF] The Potential Role of Nitric Oxide in the Hypertrophic

F Šimko, J Šimko - Physiol. Res, 2000 - biomed.cas.cz
Left ventricular hypertrophy (LVH) is the result of interaction between a chronic
hemodynamic overload and nonhemodynamic factors. There are several lines of evidence …

Thick ascending limb sodium transport in the pathogenesis of hypertension

A Gonzalez-Vicente, F Saez… - Physiological …, 2019 - journals.physiology.org
The thick ascending limb plays a key role in maintaining water and electrolyte balance. The
importance of this segment in regulating blood pressure is evidenced by the effect of loop …